The fact that C5aR1 therapeutic inhibition performed with PMX205 treatment enhanced survival of the mice even when it was administered after infection (Fig. 7) makes C5aR1 an exciting candidate for adjuvant treatment. This evidence concerns the gene C5AR1 and infection.